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Abstract 
Myocardial infarction is a common presentation of coronary artery disease. This study was aimed to 
evaluate the effect of uric acid and lipid profile on myocardial infarction in Iraqi population. 
The study was conducted on (30) patients acute myocardial infarction, and (30) apparently healthy 
subjects were taken as control group. The level of uric acid and lipid profile was determined using colorimetric 
method. 
Patient group had significantly higher level of uric acid (P < 0.01), total cholesterol (P < 0.01), 
triglyceride (P < 0.01), low density lipoprotein (P < 0.01), very low density lipoprotein (P < 0.01) and 
significantly lower level of high density lipoprotein (P < 0.01) than control group. The results of this study also 
showed a significant difference (P < 0.01) between males and females regarding uric acid, total cholesterol, 
triglyceride, low density lipoprotein, very low density lipoprotein and high density lipoprotein in both study 
groups. 
The body weight of the patients demonstrated as body mass index showed a significant association (P < 
0.01) with the level of uric acid, total cholesterol, triglyceride, low density lipoprotein and high density 
lipoprotein in patient group. In conclusion, uric acid may have an effect on precipitating some risk factors of 
myocardial infarction. 
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Introduction 
Myocardial infarction (MI) means interruption of blood supply to a part of the heart, and it is almost 
always due to the formation of occlusive thrombus at the site of rupture or erosion of an atheromatous plague in 
coronary artery causing heart cell to die and without treatment the infarct related artery remains permanently 
occluded in 30% of patients (Bloomfield, et al. 2006). 
Uric acid is a heterocyclic organic compound with the formula C5H4N4O3 and a molecular weight of 
168 Daltons. Uric acid is the final metabolic product of purine metabolism in humans, and is excreted in urine 
(Ming, 2012). Uric acid produced from xanthine by the enzyme xanthine oxidase (Enomoto, et al.  2005).  
Hyperuricemia has been shown to increase the risk of CHD related-events such as MI independently of 
other CHD risk factors, and is linked to higher mortality rates of CHD. A recent meta-analysis of a prospective 
cohort study showed that there is a 12% increase in mortality with each extra 1 mg/dL of uric acid in a person 
with CHD (Kim, et al. 2010).  
The presence of hyperuricemia increases the risk of CHD by approximately 70% in women, but not in 
men (Wheeler, et al. 2005). Lipids are heterogeneous group of compounds which are water-insoluble but soluble 
in nonpolar solvents such as alcohol, ether, chloroform, benzene (Carl, A. and Edward R. 2008). Lipids are 
presented in the plasma as fatty acids, triglycerides, cholesterol and phospholipids, they can be transported as 
lipoprotein particles, i.e. associated with proteins (Smith, et al. 2000). lipids play crucial roles as coenzymes, 
electron carriers and emulsifying agents in the digestive tract, hormones and intracellular messengers (David L. 
and Michael M., 2005). 
  Lipoproteins are macromolecular complexes that carry various lipids and proteins in plasma (Ginsberg 
HN. 1998).  Several major classes of lipoproteins have been defined by their physical and chemical 
characteristics, particularly by their flotation characteristics during ultracentrifugation (Young, et al. 2007). The 
lipids are mainly free and esterified cholesterol, triglycerides, and phospholipids. The hydrophobic triglyceride 
and cholesteryl esters compose the core of the lipoproteins, which is covered by a unilamellar surface that 
contains mainly the amphipathic (both hydrophobic and hydrophilic) phospholipids and smaller amounts of free 
cholesterol and proteins. Apo B100 is required for the secretion of hepatic-derived VLDL, IDL, and LDL. Apo 
B48 is a truncated form of Apo B100 that is required for secretion of chylomicrons from the small intestine 
(Merkel, et al. 2005). 
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Material and methods 
The MI group who subjected to this study were (30) persons  in the age group ranging from 38 – 90 
years , the mean ± standard deviation (SD) was (60 ± 12.2 years). This group comprised of  males (60%), with 
their age ranging from 38 - 70 years old, the mean ± SD was (55.5 ± 10.4  years) , and  females (40%) with age 
ranging from 50 - 90 years, and mean ± SD was (66.7 ± 11.9 years).   
        Thirty apparently healthy individuals were taken as a control group of the age ranging from 38 – 79 years, 
the mean ± standard deviation (SD) was (57.87 ± 13.68 years). This group comprised of  males (57%) their age 
ranging from 38 - 80 years , mean ± SD was (61.76 ±  13.57 years), and  females (43%) their age ranging from 
39 - 79 years ,  mean ± SD was ( 52.8 ± 12.5 years) . 
       The age and sex of this group were matched to age and sex of MI group, where statistical analysis 
showed non-significant differences in the age and sex between patient and control groups (p > 0.05). 
A permission was taken from all subjects to contribute to this study after they were told about the aim 
and advantages of this study. 
- The level of serum uric acid was determined by using colorimetric method mentioned earlier (Carl, A. and 
Edward R.2006). 
- Cholesterol concentration was determined enzymatically according to the method described earlier 
(Allain, 1978). 
- Triglycerides concentration was determined enzymatically according to the method described by Allain 
Fossati and Prencipe
 
(Fossati P. and Prencip L. 1982). 
- HDL level determined colorimetrically as mentioned earlier (Carl, A. and Edward R. 2006).  
- VLDL concentration was calculated by dividing triglycerides value by 2.22 (Godkar, P. 1994).    
- LDL concentration was calculated by using Friedewald equation (Godkar, P. 1994).              
[ 
Determination of risk factors of the patient groups 
Patients were considered hypertensive when they were already on antihypertensive treatments or their 
systolic blood pressure was ≥ 140 and diastolic blood pressure was ≥ 90 in two reading times with 24 hours 
interval (Kasper, et al. 2005).  Patients were considered as diabetic when they had history of diabetes, on 
treatment including diet regime or when fasting blood glucose ≥ 7.0 mmol/L (126 mg/dl) or random blood 
glucose ≥ 11.1 (200 mg/dl) (WHO, 2006). Diabetic patients included in this study were of type 2 diabetes with 
disease duration of about 10-13 years. 
Body mass index (BMI) is a ratio of a person weight to height; it commonly used to classify weight as 
healthy or unhealthy. BMI calculated as follow (Whitlock, et al.2005):  
                                      BMI (kg/m2) = weight (kg) / height (m2) 
 
Results 
Plasma concentration of uric acid was increased significantly in patients with MI when compared with 
control group  (P ˂ 0.01), as illustrated in figure (1). 
 
 
Figure (1) Plasma uric acid concentration (µmolar) in study groups. 
 
The level of uric acid was compared for both genders, age and BMI groups for both study groups, as 
shown in table (1). 
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Table (1) the effect of gender, age and BMI on uric acid level in study groups. 
 
Parameter Subclass 
Uric acid (µmolar) Mean ± SD 
MI group Control group 
Gender 
Male 374.9 ± 35* 303.3 ± 32.8 
Female 291.75 ± 25 281.8 ± 24.6 
Age 
(years) 
30-39 year 328 ± 0 292.9 ± 36.6 
40-49 year 334.1 ± 24.3 278 ± 33.5 
50-59 year 312.4 ± 39.7 279.9 ± 27 
60-69 year 320.7 ± 31.3 304.4 ± 17 
70-79 year 330.6 ± 31.7 317.5 ± 13 





Under-weight 272.5 ± 24* 293 ± 0 
Normal weight 328.1 ± 36.8 289.3 ± 30.8 
Over-weight 395.2 ± 26.4 304 ± 34.5 
 
* Significant difference (P ˂ 0.05).                ** SD = standard deviation. 
 
The present study showed a significant difference in the level of uric acid between males and females in 
MI group (P ˂ 0.05). There was no significant association between age and uric acid in MI group (r = 0.2, P > 
0.05). The present study also showed that the over-weight individuals had significantly higher level of uric acid 
than normal or under-weight individuals in both study groups (P ˂ 0.05). 
To demonstrate the effect of risk factors of MI on uric acid concentration, the correlation between uric 
acid serum level of MI patients with each of these risk factors was tested, as shown in table (2). 
 
Table (2) Effect of stroke risk factors on uric acid level 
          Risk factor 
 
   Parameter 
Uric acid (µmolar) 
O.R. 
Confidence 




Normotensive 32 (52%) 30 (48%) 
2.7* 1 – 7 S 
Hypertensive 8 (28%) 20 (72%) 
Smoking 
Non-smokers 31 (46%) 37 (54%) 
1.2 0.46 - 3.2 NS 
Smokers 9 (41%) 13 (59%) 
Diabetes 
mellitus 
Non-diabetics 33 (48%) 30 (52%) 
3.1* 1.2 - 8.5 S 
Diabetics 7 (26%) 20 (74%) 
* Significant difference (P ˂ 0.05). 
The table (2) showed a significant difference in the level of uric acid (P < 0.05) between hypertensive and 
normotensive patients in MI group. The table (2) also showed a significant difference in the level of uric acid (P < 
0.05) between diabetic and non-diabetic patients in both stroke and MI groups.  
The table (3) shows the mean level of serum lipids in study groups: 
 
Table (3) Plasma concentration of lipid profile of study groups. 
Parameter 
Study group 
MI group Control group 
Total cholesterol (mg/dl) 206.9 ± 39.7 160.6 ± 47.1 
Triglycerides (mg/dl) 201 ± 84.6 141.3 ± 39.5 
HDL (mg/dl) 34.4 ± 10.3 45.6 ± 8.8 
LDL (mg/dl) 132.3 ± 41.5 86.7 ± 53.4 
VLDL (mg/dl) 40.2 ± 17 28.3 ± 7.9 
Non-HDL (mg/dl) 172.5 ± 40.4 115 ± 50.5 
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The table (3) showed that there was a significant difference between MI group and control group in all lipid 
profile parameters. The level of lipid profile was compared for both genders for each of the study groups, as shown 
in table (4). 
 
Table (4) Effect of gender on lipid profile of study groups. 
                      Study group 
  Parameter 
MI group Control group 
Male female Male female 
Total cholesterol (mg/dl) 236 ± 14* 180.2 ± 16 179 ± 14.2 136 ± 16.2 
TG (mg/dl) 217 ± 8.3* 192 ± 17.7 155.7 ± 16 122.6 ± 13 
HDL (mg/dl) 22.7 ± 4.2* 46.9 ± 9.7 41.5 ± 6.5 51.2 ± 8.5 
LDL (mg/dl) 167 ± 17* 95 ± 15.2 107 ± 16.1 60.4 ± 8.2 
VLDL (mg/dl) 43.4 ± 5.6* 38.4 ± 4.2 31.1 ± 5.1 24.5 ± 4.8 
 
* Significant difference (P ˂ 0.05). 
 
The present study showed that the levels of total cholesterol, triglyceride and LDL cholesterol were 
significantly lower in females than that of males, while the level of HDL cholesterol in females was significantly 
higher than that of males in both study groups (P < 0.05).  
The association between BMI and lipid parameters was shown in table (6). 
 
Table (6) Effect of BMI on lipid profile of study groups. 
      m          Study group 
 Parameter 
MI group Control group 
r P r P 
Total cholesterol (mg/dl) 0.42 S 0.53 HS 
Triglycerides (mg/dl) 0.57 HS 0.61 HS 
HDL (mg/dl) -0.6 HS -0.4 S 
LDL (mg/dl) 0.41 S 0.39 S 
VLDL (mg/dl) 0.3 NS 0.2 NS 
 
r: Correlation coefficient.   S: Significant difference (P ˂ 0.05), HS: Highly significant difference (P ˂ 0.01). 
NS: Non significant difference (P ˃ 0.05). 
 
The present study showed that total cholesterol, triglyceride and LDL had a significant positive 
association with BMI in both study groups, while a significant negative association was noticed between HDL and 
BMI in both study groups. 
 
Discussion 
Several mechanisms could cause the uric acid metabolic pathway to be a cardiovascular risk factor. Uric 
acid may stimulate vascular smooth cell proliferation, and reduce vascular nitric oxide production (Dawson, et al. 
2007).  
There are several suggested mediators of the deleterious effect of uric acid on cardiovascular health 
such as dysfunctional vascular endothelium; adhesiveness of platelets and granulocytes, subsequent release of 
cytokines and their effect on atherosclerotic plaques, and oxidative stress (Ambarish, et al. 2013). 
A recent study found that hyperuricemia was significantly associated with poor outcomes in cardiac 
disease patients such as MI patients without chronic kidney disease, but not in hyperuricemic persons with renal 
failure (Filippatos, et al. 2011).  
The effect of gender on uric acid level is well explained by the hormonal differences between males and 
females, since the estrogen have an impact on reducing the uric acid level in the blood (Woo, et al. 1994). 
The association between BMI and uric acid may be explained by the fact that obesity affects urate 
metabolism, by decreasing urate clearance and increasing urate production (Omar, et al. 2007).  
  Uric acid has been suggested to play a role in the pathogenesis of early onset hypertension (Jules, 2014) 
but the levels may tend to dampen with age where stiffening of the aorta, activation of the renin-angiostensin 
system and renal vasoconstriction have a role to play (Teng, et al. 2011).  
Chronic inflammation and endothelial dysfunction, as observed in patients with hyperuricemia, are likely 
to have participation in the mechanisms through which this substance may affect renal structure and 
operation leading to the genesis of hypertension (Zoccali, et al. 2006).  
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The relatively accepted explanation is that uric acid is a substance that its production increased by the 
organism to counteract the increased oxidative stress associated with diabetes mellitus thus, the increase of uric 
acid level in diabetes mellitus representing only a defense mechanism (Sérgio, et al. 2012). 
Regarding lipid profile, Women have significantly different lipid and lipoprotein profiles than men 
regardless of age and menopausal status (Tremollieres, et al. 1999).  
Presumably these differences are due to the different levels of circulating sex hormones, specifically 
estrogens and androgens in women versus men. It has been reported that women have higher production rates of 
Apo-I, the major HDL Apo protein, than do men, and that levels and production rates of Apo-I correlate well with 




Allain C., et al. (1974). Clin. Chem.; 20/4. 470–475. 
 
Ambarish Dutta, et al., (2013), Uric Acid Measurement Improves Prediction of Cardiovascular Mortality in 
Later Life. JAGS 61:319–326. 
 
Bloomfield P.,Bradbury A, Grubb N.R.,Newby D.E, (2006), chapter 18 In:Boon N.A., Colledge N. R .,Walker 
B.R. 20 Edition,  Davidson`s Principle and Practice of     Medicine, UK:  Churchill Livingstone Elsevier, 
pp 591.   
 
Carl A. and Edward R. (2006). Tietz text book of clinical Biochemistery and Molecular Diagnostics; 4th ed. 948. 
 
Carl A., Edward R. and David E.. (2008), Vitamins and trace  elements. Tietz Fundamentals of clinical 
chemistry,; 6th  ed. 476–508. 
 
David L. and Michael M. (2005). Lipids. Lehninger  Principle Of   Biochemistry; 4th  ed. 10:343–368. 
 
Dawson J, Quinn T, Walters M: (2007), Uric acid reduction: a new paradigm in the management of 
cardiovascular risk? Curr Med Chem, 14:1879–1886. 
 
Enomoto, Atsushi ,Endou and Hitoshi ,(2005), "Roles of organic anion transporters (OATs) and a urate 
transporter (URAT1) in the pathophysiology of human disease". Clinical and Experimental Nephrology;9 
(3): 195–205.  
 
Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE, Sanders PW, Pitt B, Anker SD, Ahmed A: 
(2011), Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic 
insights from epidemiological data. Eur Heart J, 32:712–720. 
 
Fossati P. and Prencip L. (1982). Clin. Chem.; 28: 2077–2080. 
 
Ginsberg HN. (1998), Lipoprotein physiology. Endocrinol Metab Clin North Am.;27:503–519. 
 
Godkar P. (1994). Textbook of Medical Technology, Clinical  Biochemistry; Principles and Practice, Bhalani 
publishing house, Bombay. India. 223–225. 
 
J. Woo, R. Swaminathan, C. Cockram, E. Lau' and A. Chan, (1994), Association between serum uric acid and 
some cardiovascular risk factors in a Chinese population, Postgrad Med J 70, 486 – 491. 
Jules C. Assob, et al., (2014), The Relationship between Uric Acid and Hypertension in Adults in Fako Division, 
SW Region Cameroon, Nguedia Assob et al., J Nutr Food Sci, 4:1. 
 
Kasper DL, Braunwald E,Fauci AS,Hauser SL ,Longom DL and Jameson J L, (2005), HARRISON`S 
PRINCIPLE OF INTERNAL MEDICINE,(16th Edition) McGraw-Hill,16th Edition. (1430-68). 
 
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. (2010), Hyperuricemia and coronary heart 
disease: a systematic review and meta-analysis. Arthritis care & research.; 62:170–80. 
 
Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J. Apolipoprotein. 
(2005), AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with 
proteoglycan-bound lipoprotein lipase. J Biol Chem.;280:21553–21560. 
 
Ming Jin, et al., (2012), Uric Acid, Hyperuricemia and Vascular Diseases. NIH Public Access,17: 656–669. 
Omar K. Alboqai, et al., (2007), Obesity and Serum Uric Acid, Bahrain Medical Bulletin, Vol. 29, No. 3. 
 
Sérgio Lamego Rodrigues, et al., (2012), Gender distribution of serum uric acid and cardiovascular risk factors: 
population based study, Arq. Bras. Cardiol. vol.98 no.1. 
 
Smith A., Beckett G., Walker J., et al. (2000), Disorders of plasma lipids and lipoproteins. Lectures Notes on 
Clinical Biochemistry,; 6th  ed. Blackwell Science. 101–104. 
 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.4, No.22, 2014 
 
24 
Syed Shahid Habib, Muhammad Aslam, Waqas Hameed., (2005), GENDER DIFFERENCES IN LIPIDS AND 
LIPOPROTEIN (a) PROFILES IN HEALTHY INDIVIDUALS AND PATIENTS WITH TYPE 2 
DIABETES MELLITUS, Pak J Physiol;1(1-2). 
 
Teng F, Zhu R, Zou C, Xue Y, Yang M, et al. (2011) Interaction between serum uric acid and triglycerides in 
relation to blood pressure. J Human Hypertens 25: 686-691. 
 
Tremollieres FA, Pouilles JM, Cauneille C, Ribot C. (1999), Coronary heart disease risk factors and menopause: 
a study in 1684 French women. Atherosclerosis Feb;142(2):415- 23. 
 
Trinder P. (1969). Clin. Chemistry; 6: 27–29. 
 
Wheeler JG, Juzwishin KD, Eiriksdottir G, Gudnason V, Danesh J. (2005), Serum uric acid and coronary heart 
disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med.; 
2:e76.  
 
Whitlock E., Williams S., Gold R., et al. (2005). Screening and interventions for overweight in children and 
adolescents: a summary of evidence for the U.S. preventive Services Task Force. Pediatrics. ; 116 
(1):e125-e144. 
 
World Health Organization Department of Non communicable Disease Surveillance (2006). "Definition, 
Diagnosis and Classification of Diabetes Mellitus and its Complications. 
 
Young SG, Davies BS, Fong LG, Gin P, Weinstein MM, Bensadoun A, Beigneux AP. GPIHBP1: (2007), an 
endothelial cell molecule important for the lipolytic processing of chylomicrons. Curr Opin Lipidol.;18: 
389–396. 
 
Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F. (2006), Uric acid and endothelial dysfunction in essential 
















The IISTE is a pioneer in the Open-Access hosting service and academic event 
management.  The aim of the firm is Accelerating Global Knowledge Sharing. 
 
More information about the firm can be found on the homepage:  
http://www.iiste.org 
 
CALL FOR JOURNAL PAPERS 
There are more than 30 peer-reviewed academic journals hosted under the hosting 
platform.   
Prospective authors of journals can find the submission instruction on the 
following page: http://www.iiste.org/journals/  All the journals articles are available 
online to the readers all over the world without financial, legal, or technical barriers 
other than those inseparable from gaining access to the internet itself.  Paper version 
of the journals is also available upon request of readers and authors.  
 
MORE RESOURCES 
Book publication information: http://www.iiste.org/book/ 
 
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische 
Zeitschriftenbibliothek EZB, Open J-Gate, OCLC WorldCat, Universe Digtial 
Library , NewJour, Google Scholar 
 
 
